Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825270 | Clinical Therapeutics | 2014 | 7 Pages |
Abstract
The test and reference tablets met the regulatory criteria for bioequivalence as defined by the China Food and Drug Administration. Both formulations were well tolerated. Chinese Clinical Trials Registry identifier: ChiCTR-TTRCC-13003723.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jianzhong MD, PhD, Huili MS, Xingjiang MS, Guolan MS, Lihua MD, PhD, Meixiang PhD, You MS, Yunliang PhD, Jian MS,